ANUH PHARMA LTD. - 506260 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to the Regulation-30of SEBI (LODR) Regulations, 2015, please find enclosed the details of investor calls held on Monday, 30th May, 2022. ANUH PHARMA LTD. - 506260 - Announcement under Regulation 30 (LODR)-Investor Presentation
We are submitting herewith our Company''s Investor Presentation for the month of May, 2022. ANUH PHARMA LTD. - 506260 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Pursuant to the provisions of Regulation 24A of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the Annual Secretarial Compliance Report for the Financial Year ended March 31, 2022 issued by Sanjay Doshi & Associates, Company Secretaries. ANUH PHARMA LTD. - 506260 - Revised Submission Of Audited Financial Results Along With Auditor''s Report For The Year Ended March 31, 2022 & Declaration
With reference to our previous submission dated 14th May, 2022, please find enclosed herewith our revised submission of Audited Financial Results along with Auditor's Report for the year ended 31st March, 2022 & Declaration from Joint Managing Directors w.r.t. Audit Report with unmodified opinion to the Audited Financial Results for the financial year ended 31st March, 2022. ANUH PHARMA LTD. - 506260 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find enclosed herewith the copy of newspaper advertisement with respect to the Audited Financial Results for the quarter and year ended 31" March, 2022, published in the Financial Express and Mumbai Lakshadeep on Sunday, May 15, 2022 in compliance with Regulation 4 7 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. ANUH PHARMA LTD. - 506260 - Intimation Pursuant To Regulation 31A Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 (SEBI Listing Regulations).
We would like to inform that the Board of Directors of the Company in their meeting held on May 14, 2022, have considered and approved the request received from few Promoters/ Promoter Group of the Company seeking reclassification of their shareholding from ''Promoters/ Promoter Group'' to ''Public'' category. As required under SEBI Listing Regulations, we also enclose herewith extract of Minutes of Meeting of the Board of Directors held on May 14, 2022 approving such re-classification, for your reference. The Company will seek Members'' approval for the reclassification in line with the provisions of Regulation 31A of SEBI Listing Regulations in due course. Request you to kindly take the same on record and oblige. ANUH PHARMA LTD. - 506260 - Corporate Action-Board approves Dividend
Anuh Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 14, 2022, inter alia, has recommended final dividend of Rs. 1.75/- per equity shares of face value of Rs. 5/- each (i.e. 35%) for the financial year ended March 31, 2022, subject to the approval of the Shareholders at the ensuing Annual General Meeting of the Company. ANUH PHARMA LTD. - 506260 - Submission Of Audited Financial Results Along With Auditor''s Report For The Year Ended March 31, 2022 & Declaration.
Pursuant to the provisions of Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the following: 1. Audited Financial Results for the quarter & year ended March 31, 2022; and 2. Auditor''s Report on quarterly financial results and year to date results for the year ended 31st March, 2022; and 3. Declaration from Joint Managing Directors w.r.t. Audit Report with unmodified opinion to the Audited Financial Results for the financial year ended 31st March, 2022. ANUH PHARMA LTD. - 506260 - Board recommends Final Dividend
Anuh Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 14, 2022, inter alia has recommended final dividend of Rs. 1.75/- per equity share of face value of Rs. 5/- each (i.e. 35%) for the Financial Year ended March 31, 2022, subject to the approval of the Shareholders at the ensuing Annual General Meeting of the Company. ANUH PHARMA LTD. - 506260 - Board Meeting Outcome for Board Meeting Outcome For Outcome Of Board Meeting Held On 14Th May 2022.
Outcome of Board Meeting held on 14th May 2022.